BERLIN, Sept. 5, 2025 /PRNewswire/ — TCL, a global leader in consumer electronics and the world’s No.1 Mini LED and Ultra-large^[1] TV brand, delivered an inspiring show at IFA 2025 under the theme “Inspire Greatness”. From cutting-edge audiovisual displays, AI-powered home appliances, and smart connected mobile devices, to the global debut of TCL NXTHOME^TM and a series of sustainable innovations, the exhibition showcased TCL’s pursuit to enhance everyday life through innovative products, fashionable and premium design, and vibrant experiences.

Featuring a dedicated sports-themed design igniting an athletic vibe at IFA 2025 alongside the brand’s latest technological innovations, the exhibition also underscored TCL’s commitment to connecting audiences worldwide through the transformative power of technology, elevating sports experiences for fans and athletes alike by blending innovation with passion to inspire greatness on and off the field.

Innovative Audiovisual Displays Offer Immersive Entertainment for Every Viewer

One of the highlights was TCL’s 2025 flagship model—the C9K Premium QD-Mini LED TV. With its CrystalGlow WHVA panel, Virtually ZeroBorder design, advanced QLED technology, and Audio by Bang & Olufsen, the C9K combines breakthrough display engineering, immersive design, and premium audio into one masterwork, offering front-row immersion for an unparalleled game viewing experience.

Since launching the world’s first QD-Mini LED TV in 2019, TCL has continued to reinforce its leadership in display technology with its evolving QD-Mini LED technology. Combining precise Mini LED backlighting with the world’s leading QLED technology, this innovation delivers OLED-class contrast and a wide color gamut, along with higher peak brightness, longer lifespan, and better value—especially in ultra-large TV sizes—all while utilizing low-energy backlights and high-efficiency panels for a lighter environmental footprint.

Expanding beyond TVs, TCL also introduced its QD-Mini LED technology to an ultra-wide monitor for the first time at IFA with the 57R94 Dual 4K, delivering immersive visuals for gaming and multi-window productivity.

In audio, TCL also featured additional innovative experiences in collaboration with Dolby. TCL showcased the new Z100 Wireless Free Sound Speaker. When paired with TCL TVs that support Dolby Atmos FlexConnect, users can choose how they want to arrange their speakers bringing freedom and flexibility to incredible immersive home theater experiences. TCL also announced that the next generation of Dolby Vision, Dolby Vision 2, is planned to come soon to TCL TVs to further elevate the TV viewing experience.

AI-Powered Smart Living Redefines Game-day Moments at Home

Underpinning TCL’s portfolio at IFA 2025 was the company’s human-centric AI, built on Eagle Lab’s Turing Platform, which enables smarter, more personalized experiences across TVs, air conditioners, refrigerators, washing machines, smartphones, and more.

The TCL FreshIN 3.0 Air Conditioner features AI Health, Voice Control, and AI Energy Saving, offering ultra-quiet fresh air with QuadruPuri purification, while VoxIN, BreezeIN, and SaveIN AI enhance convenience, comfort, and energy efficiency. In the kitchen, the Free Built-in Refrigerator with T-Fresh Technology ensures a hygienic environment for food and quick access to chilled half-time snacks and drinks. The SuperDrum Series Washer & Dryer Pair with smart Wi-Fi connectivity allows users to manage laundry remotely, while Auto Dose technology automatically dispenses the perfect amount of detergent.

In mobile devices, the new TCL NXTPAPER 60 Ultra is equipped with the latest NXTPAPER 4.0 technology and a 7.2-inch natural light display, delivering the most comprehensive eye-comfort smartphone experience yet. The NXTPAPER 11 Plus Tablet extends this same level of comfort to a larger screen together with built-in AI features like Writing Assist and Text Assist to enhance productivity for study, work, and daily life.

Adding companionship to multiple scenarios was TCL AiMe—the world’s first modular AI companion robot. Making its first appearance in Europe at the show, TCL AiMe blends lifelike expressions, interactive AI, and smart living features to turn everyday moments into opportunities to imagine, play, and connect.

Other notable showcases include: RayNeo X3 Pro—the world’s smallest full-color MicroLED AR glasses, offering real-time translation, AI interaction, spatial navigation, and smart payment; the safety-enhanced TCL MOVETIME MT48 Kids Smartwatch; the portable TCL PlayCube Projector; the TCL D2R Max 3D Face & Palm Vein Retrofit Smart Lock; and a seamless Human-Vehicle-Home ecosystem solution.

Vibrant Experiences Come Alive with the Olympic Spirit

As a Worldwide Olympic Partner, TCL brought the excitement of the Winter Olympics to IFA 2025 with a series of interactive experiences inspired by the upcoming Milano Cortina 2026 games. Among them was a dedicated Winter Olympics Zone featuring mascots Milo and Tina that made a memorable stop for IFA visitors. Adding to the excitement, TCL also highlighted Team TCL, a dedicated support program for TCL’s participation in the Olympic Games.

Global Debut of TCL NXTHOME^TM Brings Premium Art into Everyday Life

Making its global debut at IFA 2025 was TCL NXTHOME^TM. Shaped by TCLArt’s vision to “Inspire the Artists of Tomorrow,” TCL NXTHOME^TM blends smart home solutions, lifestyle appliances, with premium collaborations from global partners including Audio by Bang & Olufsen, Roche Bobois, Chris Lefteri Design, Castelli 1938, and Alcantara.

From smart freshness in the kitchen to artful living in the living room, cinematic sound in the home theater, creative energy in the gaming zone, and restful relaxation in the bedroom, TCL NXTHOME^TM redefines modern living where innovation meets artistry.

Sustainability through Green Innovation

This year, TCL also showcased how it is advancing practical sustainability across its entire value chain. TCL SunPower Home Energy Solutions integrate solar panels, battery storage, an EV charger, an energy controller, and a heat pump into one intelligent app-managed system that allows homes to store low-cost energy for later, while TCL’s new solar panels deliver long-lasting, consistent output.

Brand-new for IFA 2025 was TCL ECORA™—a breakthrough sustainable material co-developed with Chris Lefteri Design. Made from recycled porcelain ceramics sourced from Jingdezhen—the cradle of Chinese porcelain—TCL ECORA™ turns ceramic waste into high-performance plastic fillers offering improved durability and reduced carbon emissions while bringing centuries-old craftsmanship into modern design.

From edge-to-edge screens that erase the boundary between spectator and spectacle, to personalized AI technologies and energy systems that quietly conserve power in the background, TCL’s IFA 2025 portfolio is leveraging world-class innovation to elevate the way we experience sport and entertainment at home and beyond.

About TCL

TCL is a leading consumer electronics brand and a global leader in the television industry. Operating in over 160 markets worldwide, TCL specializes in the research, development, and manufacturing of consumer electronics products, including TVs, audio systems, home appliances, mobile devices, smart glasses, commercial displays, and more. For additional information, visit the TCL website at https://www.tcl.com.

GOTHENBURG, Sweden, Sept. 5, 2025 /PRNewswire/ — Together with project partners Sev, Capture Energy and IVL, Minesto completed a planning and project set-up workshop for the 25 MSEK Microgrid Project awarded by Swedish Energy Agency. In parallel with the project, Minesto has added an integration of two local end-user applications of tidal energy in the Faroe Islands to strengthen customer involvement.

The session was conducted at Minesto’s head office in Göteborg. With the 1,5 days planning meeting completed, Minesto and partners have laid a good foundation to deliver a microgrid turnkey installation in Vestmanna, Faroe Islands.

“We are off to a good start delivering a tidal energy microgrid system with the capacity to offer base-load renewable energy to both local needs in the Faroe Islands and further to millions of users on a global market,” said Johannes Hüffmeier, COO of Minesto.

In parallel, work with integration of user applications is initiated together with Sev and local end users with the ambition to increase renewable energy content. Potential users in Vestmanna are in focus, with EV charging and an industrial process as the two prioritized areas for reduction of fossil energy consumption via electrification.

“Right at the start, we want to add delivery of tidal energy into electrification applications for the customer value of our microgrid to be proven and demonstrated. Small-scale electrification to reduce CO2 emissions is a core component in the global energy transition as well as in our sales growth projections,” said Dr Martin Edlund, CEO of Minesto.

For additional information, please contact
Cecilia Sernhage, Chief Communications Officer
+46 735 23 71 58
ir@minesto.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/minesto-ab/r/minesto-kicks-off-microgrid-project-with-partners-and-adds-local-end-user-applications,c4230271

SHANGHAI, Sept. 5, 2025 /PRNewswire/ — Immunofoco, a clinical-stage biotechnology company, focused on developing novel cell therapies for solid tumors, has been selected for the prestigious “Forbes Asia 100 to Watch 2025” list. This annual list, compiled by the editors of Forbes Asia, spotlights outstanding small companies and startups across the Asia-Pacific region that are recognized for their innovation and strong growth potential.

Immunofoco stands out as one of only nine companies from Mainland China and one of two in the Biotechnology & Healthcare sector on the list, highlighting its significant impact and leading position in the field.

Forbes Asia 100 to Watch 2025 list is the result of a rigorous, multi-stage selection process. Companies were evaluated based on their positive impact and contributions to the industry and region, market fit, promising business models, degree of innovation, strong revenue growth, and ability to attract funding. This year’s list features 100 companies from 16 countries and territories, with the Biotechnology & Healthcare sector being the most represented, highlighting the region’s focus on innovative life sciences.

Groundbreaking CAR-T Studies Recognized by Leading International Publications
Immunofoco’s latest research on its EpCAM-targeted CAR-T cell therapy, IMC001, has been published in Molecular Therapy, demonstrating compelling antitumor activity and a favorable safety profile in preclinical models and clinical trials involving patients with advanced gastric cancer. Additionally, the company’s Peri Cruiser® technology platform—developed in collaboration with Professor Bo Zhai from Tongji University-affiliated Shanghai East Hospital and other teams—was featured as a cover article in Science Translational Medicine. This innovative platform regulates the in vivo distribution of CAR-T cells, significantly reducing on-target, off-tumor toxicity while preserving antitumor efficacy and controlling metastasis, offering a transformative strategy for CAR-T therapy in solid tumors.

The Phase I registrational trial for IMC002 has been successfully completed, demonstrating a favorable preliminary safety and efficacy profile. In a recent case, a patient with advanced gastric cancer and liver metastases, who had progressed following multiple prior lines of therapy, achieved a sustained complete response (CR) one year after a single infusion of IMC002.

Earlier data from an Investigator-Initiated Trial (IIT) showed another patient with advanced, unresectable gastric cancer successfully underwent curative resection 44 weeks after a single IMC002 infusion. Pathological examination confirmed a pathological complete response (pCR), with no signs of tumor recurrence in follow-up imaging scans at 2, 6, 9, and 14 months post-surgery, demonstrating a sustained CR that has been maintained for two years post-infusion. These cases offer new hope for long-term survival in patients with advanced solid tumors.

Innovative Platform: Overcoming Traditional Limitations

Further bolstering its innovative profile, Immunofoco’s novel In Vivo technology platform was selected for a poster presentation at the ASGCT 2025 Annual Meeting. This platform utilizes a novel lentiviral vector pseudotyped with MxV glycoprotein (MxV-G) and incorporates T-cell-specific targeting molecules. This innovative design enables the direct in vivo delivery of the CAR gene, potentially addressing key limitations of conventional CAR-T therapies, including lengthy, complex, and costly manufacturing.

Capital Recognition: Fueling Accelerated Development and Global Expansion

As of the nomination date, Immunofoco has raised approximately $70 million in total funding from renowned investors, including Vivo Capital, SDIC Venture Capital Co., Ltd. (SDICVC), Delian Capital, ZhenFund, and Bohe Angel. The proceeds are being used to accelerate the registrational clinical studies of core products like IMC002 and support the company’s strategic international expansion plans, reflecting strong market confidence in its technology and prospects.

“This recognition from Forbes Asia is a significant validation of our team’s pioneering work in tackling the fundamental challenges of cell therapy for solid tumors, particularly the compelling sustained CR data observed with IMC002 and our innovative In Vivo platform,” said Dr. Minmin Sun, Founder, Chairman, and CEO of Immunofoco. “This achievement not only belongs to Immunofoco but also highlights the growing impact of Chinese biotech innovation on the global stage. We are committed to advancing our global development pipeline to fulfill our mission of overcoming solid tumors and delivering life-changing cell therapies to patients worldwide.”

About Immunofoco
Immunofoco has pioneered a clinical strategy focused on “curing the solid tumors by treating them as hematologic malignancies”, addressing the challenges in solid tumor treatment, and the clinical advantages of treating hematologic malignancies. To improve the safety of CAR-T products, counteract tumor heterogeneity, and to enhance their effectiveness in tumor amplification and infiltration, we have developed innovative platforms such as Peri Cruiser®, SNR, and T-Booster. Driven by the clinical outcomes, our company maintains an extensive spectrum of product pipeline. Notably, our IMC002 (CLDN18.2 CAR-T) has been granted Fast Track designation and orphan drug designations (ODDs) for gastric and pancreatic cancers by the U.S. FDA, and its IND application received approval in both the United States and China in April 2023. Similarly, our IMC001 (EpCAM CAR-T) product obtained ODD from the U.S. FDA in August 2023, and its IND application has been approved in both the U.S. and China in February 2024, followed by the approval of a second IND in China in March 2025. The IMC008 (SNR CAR-T) product has rapidly moved to the IIT stage and received two ODD approvals from the U.S. FDA in August 2023, for the treatment of gastric cancer and pancreatic cancer, respectively. Embodying the ethos of “collaboration, aspiration, and dedication for the best clinical results,” our company brings together industry talents and experts to develop innovative cell therapies that offer enduring survival benefits for patients with solid tumors. For further details about Immunofoco, please visit our website at www.immunofoco.com.